Cargando…

Commentary: Target Intestinal Microbiota to Alleviate Disease Progression in Amyotrophic Lateral Sclerosis

Detalles Bibliográficos
Autor principal:	Sun, Jun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5690562/ https://www.ncbi.nlm.nih.gov/pubmed/29152613

Ejemplares similares

Target Metabolites to Slow Down Progression of Amyotrophic Lateral Sclerosis in Mice
por: Ogbu, Destiny, et al.
Publicado: (2022)

Predicting disease progression in amyotrophic lateral sclerosis
por: Taylor, Albert A., et al.
Publicado: (2016)

Quantifying Disease Progression in Amyotrophic Lateral Sclerosis
por: Simon, Neil G, et al.
Publicado: (2014)

Amyotrophic Lateral Sclerosis: A Focus on Disease Progression
por: Calvo, Ana C., et al.
Publicado: (2014)

Endogenous regulatory T lymphocytes ameliorate amyotrophic lateral sclerosis in mice and correlate with disease progression in patients with amyotrophic lateral sclerosis
por: Beers, David R., et al.
Publicado: (2011)

Progress in Therapy Development for Amyotrophic Lateral Sclerosis
por: Venkova-Hristova, Kalina, et al.
Publicado: (2012)

Amyotrophic Lateral Sclerosis and Progressive Muscular Atrophy
por: Williamson, R. T.
Publicado: (1907)

Leaky intestine and impaired microbiome in an amyotrophic lateral sclerosis mouse model
por: Wu, Shaoping, et al.
Publicado: (2015)

Intestinal microbiota composition in patients with amyotrophic lateral sclerosis: establishment of bacterial and archaeal communities analyses
por: Zhai, Chao-Di, et al.
Publicado: (2019)

Modelling amyotrophic lateral sclerosis: progress and possibilities
por: Van Damme, Philip, et al.
Publicado: (2017)

Retrotransposons in the development and progression of amyotrophic lateral sclerosis
por: Savage, Abigail L, et al.
Publicado: (2019)

Creatine Kinase and Progression Rate in Amyotrophic Lateral Sclerosis
por: Ceccanti, Marco, et al.
Publicado: (2020)

Apelin Deficiency Accelerates the Progression of Amyotrophic Lateral Sclerosis
por: Kasai, Atsushi, et al.
Publicado: (2011)

Histaminergic transmission slows progression of amyotrophic lateral sclerosis
por: Apolloni, Savina, et al.
Publicado: (2019)

A Commentary on TDP-43 and DNA Damage Response in Amyotrophic Lateral Sclerosis
por: Mitra, Joy, et al.
Publicado: (2019)

Amyotrophic lateral sclerosis
por: Wijesekera, Lokesh C, et al.
Publicado: (2009)

Deep learning methods to predict amyotrophic lateral sclerosis disease progression
por: Pancotti, Corrado, et al.
Publicado: (2022)

T cell responses at diagnosis of amyotrophic lateral sclerosis predict disease progression
por: Yazdani, Solmaz, et al.
Publicado: (2022)

RNA-Targeted Therapies and Amyotrophic Lateral Sclerosis
por: Mathis, Stéphane, et al.
Publicado: (2018)

Novel therapeutic targets for amyotrophic lateral sclerosis
por: Batra, Gitika, et al.
Publicado: (2019)

Structural MRI outcomes and predictors of disease progression in amyotrophic lateral sclerosis
por: Spinelli, Edoardo G., et al.
Publicado: (2020)

Senescent-like Blood Lymphocytes and Disease Progression in Amyotrophic Lateral Sclerosis
por: Yildiz, Ozlem, et al.
Publicado: (2022)

Erratum to “Progress in Therapy Development for Amyotrophic Lateral Sclerosis”
por: Venkova-Hristova, Kalina, et al.
Publicado: (2012)

Ensuring continued progress in biomarkers for amyotrophic lateral sclerosis
por: Turner, Martin R, et al.
Publicado: (2015)

Modeling Amyotrophic Lateral Sclerosis Progression: Logic in the Logit
por: Shaabi, Afaf
Publicado: (2022)

Cerebrospinal fluid biomarkers of disease activity and progression in amyotrophic lateral sclerosis
por: Dreger, Marie, et al.
Publicado: (2022)

A prospective longitudinal study on the microbiota composition in amyotrophic lateral sclerosis
por: Di Gioia, Diana, et al.
Publicado: (2020)

Amyotrophic lateral sclerosis and cerebellum
por: Kabiljo, Renata, et al.
Publicado: (2022)

Commentary: Urinary Neopterin, a New Marker of the Neuroinflammatory Status in Amyotrophic Lateral Sclerosis
por: Espíndola, Gisele, et al.
Publicado: (2021)

A Case of Amyotrophic Lateral Sclerosis Complicated by Progressive Lipodystrophy
por: Rostowski, J., et al.
Publicado: (1953)

Amyotrophic lateral sclerosis progression in the year of the COVID-19 pandemic
por: De Marchi, Fabiola, et al.
Publicado: (2021)

Prionoids in amyotrophic lateral sclerosis
por: Gosset, Philippe, et al.
Publicado: (2022)

The microbiota restrains neurodegenerative microglia in a model of amyotrophic lateral sclerosis
por: Cox, Laura M., et al.
Publicado: (2022)

Regulatory T-lymphocytes mediate amyotrophic lateral sclerosis progression and survival
por: Henkel, Jenny S, et al.
Publicado: (2013)

An Overview of Potential Targets for Treating Amyotrophic Lateral Sclerosis and Huntington's Disease
por: de Paula, Caroline Zocatelli, et al.
Publicado: (2015)

Correlation of weight and body composition with disease progression rate in patients with amyotrophic lateral sclerosis
por: Li, Jin-Yue, et al.
Publicado: (2022)

Skeletal Muscle Remodelling as a Function of Disease Progression in Amyotrophic Lateral Sclerosis
por: Jensen, L., et al.
Publicado: (2016)

Cellular therapy to target neuroinflammation in amyotrophic lateral sclerosis
por: Rizzo, Federica, et al.
Publicado: (2013)

Amyotrophic Lateral Sclerosis and Autophagy: Dysfunction and Therapeutic Targeting
por: Amin, Azin, et al.
Publicado: (2020)

Amyotrophic lateral sclerosis and neuroregeneration
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_moug1a1e1dleoa1hs74igr6cq3